Command Palette

Search for a command to run...

Clinical Trials · NCT03018665

A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

UnknownPhase 4Exenatide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
The First Hospital of Jilin University
Enrollment
200
Start date
Feb 2017
Locations
1 site, China
Primary endpoint
Rate of Inducing Diabetes Remission
View Exenatide compound reference